HELP Cybin Inc.
Company Analysis
Latest News
🔴 Cybin is trading 6.78% down today — no clear catalyst identified
Cybin is trading 6.78% down at $13.07, with no clear company-specific announcement identified for September 18, 2026. - Its September 16 Morgan Stanley...
🟢 Cybin is trading 6.35% up in pre-market amid broad risk-on sentiment
Cybin is trading 6.35% up at $14.91 in pre-market, apparently amid broad risk-on sentiment rather than a new company-specific announcement. - Cybin advanced...
🟢 Cybin is trading 13.5% up in after-hours trading amid broad risk-on rally
Cybin is trading 13.54% up at $15.92 after regular-session trading ended at $14.02 on September 17, 2026, amid a broad risk-on rally. - The S&P 500 rose...
🟢 Cybin is trading 5% up in after-hours trading as S&P 500 and Nasdaq advanced
Cybin is trading at $14.77 (+5.35%) after broader market gains, with the S&P 500 up 1.05% and Nasdaq up 1.68%. • Regular-session trading ended at $14.01 on...
🟢 Cybin is trading 5% up today
Cybin is trading at $13.63, up 5.13% after rising from its September 11 close of $12.97. • No company-specific news release or clinical milestone was reported...
🔴 Cybin is trading 5.1% down today after hotter-than-expected August producer-price inflation
Cybin is trading 5.1% down at $12.98 after broader U.S. equity weakness following hotter-than-expected August producer-price inflation and rising Treasury...
🟢 Cybin is trading 10.2% up today despite broader market losses
Cybin is trading 10.2% up at $13.65, despite the S&P 500, Nasdaq Composite, and Dow Jones all trading lower; the specific catalyst remains unconfirmed. - On...
🟢 Cybin is trading 5.65% up today despite broader market weakness
Cybin is trading 5.65% up at $13.09, based on live price context; no confirmed catalyst is identified. - On September 9, 2026, the S&P 500, Nasdaq, and Dow...
🔴 Cybin is trading 5.3% down today amid growth-oriented biotech weakness
Cybin is trading at $11.54, down 5.30%, during the August 31, 2026 session amid weakness across growth-oriented biotech stocks. - No clear company-specific...
🔴 Cybin is trading 5.2% down today amid broad biotech-sector weakness
Cybin is trading 5.21% down at $12.55, with the decline appearing mainly tied to biotech-sector weakness. - XBI is down 2.31% as investors reduce exposure to...
🟢 Cybin is trading 5.8% up today as biotech sector gains 2.06%
Cybin is trading at $13.78, up +5.80%, after the biotechnology sector gained 2.06% during the regular session. - No fresh company-specific announcement or...
Cybin Secures Buy Ratings, TD Cowen Hikes Price Target to $62
Cybin Inc. currently maintains an average "Buy" rating from five research firms. TD Cowen recently increased its price target for the stock from $8.00 to...
🟢 Cybin is trading 5% up today on positive mRNA cancer-vaccine trial news
Cybin is trading up 5.35% now at $12.41, as biotechnology shares rally broadly on positive mRNA cancer-vaccine trial news. - No fresh company-specific...
🟢 Cybin is trading 10.8% up today ahead of August 12, 2026 earnings
Cybin is trading 10.8% up at $11.18 as investors position ahead of the company’s expected August 12, 2026 earnings release and CEO Michael Halstead’s same-day...
Cybin Surges 10.7% Ahead of Earnings — Can a Depression Drug With No Revenue Justify a $700 Million Bet?
Shares of Cybin Inc., now operating as Helus Pharma, jumped 10.7% to $11.17 on August 12 as investors piled in ahead of the company's fiscal second-quarter...
🟢 Helus Pharma (Cybin) trading up 10.69% in pre-market ahead of CEO's fireside chat at Canaccord Genuity Growth Conference
Helus Pharma, operating as Cybin, is trading 10.69% up at $11.17 as investors anticipate CEO Michael Halstead's fireside chat today, August 12, 2026. Halstead...
Cybin Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
For the fiscal quarter ending June 30, 2026, Cybin Inc. is expected to report a consensus EPS loss of -$0.80 on zero revenue, with shares currently trading at...
🔴 Cybin is trading 10.34% down today after profit-taking reversed part of its recent rally
Cybin is trading 10.34% down now at $10.41 after profit-taking reversed part of its recent rally. - Opening-day selling reversed part of the advance from...
🔴 Cybin is trading 7.75% down today after selling reversed part of recent rally
Cybin is trading 7.75% down now at $10.61 after opening-day selling reversed part of a sharp recent rally. - Shares climbed from $7.82 on July 31, 2026, to...
Cybin Taps a $14.6 Billion Dealmaker as CEO — But Can One Hire Bridge the Gap Between Clinical Promise and Commercial Reality?
Shares of Cybin Inc. (HELP) surged as much as 13% this week after the clinical-stage psychedelic-medicine company, now operating as Helus Pharma, announced it...